tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

NBTX Stock Latest News

Nanobiotix’s NBTXR3: Promising Survival Benefits and Strategic Collaborations Justify Buy Rating
RatingsNanobiotix’s NBTXR3: Promising Survival Benefits and Strategic Collaborations Justify Buy Rating
3d ago
NBTX
Nanobiotix Reveals Promising Phase 1 Results for Pancreatic Cancer Treatment
PremiumCompany Announcements
Nanobiotix Reveals Promising Phase 1 Results for Pancreatic Cancer Treatment
4d ago
6K
NBTX
Nanobiotix to Present Phase 1 Study Results on NBTXR3 in Pancreatic Cancer
PremiumCompany Announcements
Nanobiotix to Present Phase 1 Study Results on NBTXR3 in Pancreatic Cancer
9d ago
6K
NBTX
Nanobiotix Updates Voting Rights and Share Capital as of March 2025
PremiumCompany Announcements
Nanobiotix Updates Voting Rights and Share Capital as of March 2025
25d ago
6K
NBTX
Nanobiotix Reports Managerial Stock Transactions in April 2025
PremiumCompany Announcements
Nanobiotix Reports Managerial Stock Transactions in April 2025
25d ago
6K
NBTX
Nanobiotix Discloses Managerial Share Acquisitions in April 2025
PremiumCompany AnnouncementsNanobiotix Discloses Managerial Share Acquisitions in April 2025
29d ago
6K
NBTX
Nanobiotix price target lowered to $8 from $12 at Guggenheim
Premium
The Fly
Nanobiotix price target lowered to $8 from $12 at Guggenheim
1M ago
NBTX
Nanobiotix’s Promising Future: Buy Rating Backed by Data-Rich 2025 and Strategic Advancements
Premium
Ratings
Nanobiotix’s Promising Future: Buy Rating Backed by Data-Rich 2025 and Strategic Advancements
1M ago
NBTX
Nanobiotix SA ADR Reports 2024 Financial Results
PremiumCompany Announcements
Nanobiotix SA ADR Reports 2024 Financial Results
1M ago
NBTX
Nanobiotix: Strategic Partnerships and Clinical Advancements Drive Buy Rating
PremiumRatings
Nanobiotix: Strategic Partnerships and Clinical Advancements Drive Buy Rating
1M ago
NBTX
Nanobiotix Reports 2024 Progress and Financial Results
PremiumCompany Announcements
Nanobiotix Reports 2024 Progress and Financial Results
1M ago
6K
NBTX
Nanobiotix to Announce 2024 Financial Results and Host Conference Call
PremiumCompany Announcements
Nanobiotix to Announce 2024 Financial Results and Host Conference Call
1M ago
6K
NBTX
Positive Clinical Data and Strategic Partnerships Drive Buy Rating for Nanobiotix
PremiumRatingsPositive Clinical Data and Strategic Partnerships Drive Buy Rating for Nanobiotix
1M ago
NBTX
Nanobiotix Reveals Promising Phase 1 Study Results for NBTXR3 in Advanced NSCLC
Premium
Company Announcements
Nanobiotix Reveals Promising Phase 1 Study Results for NBTXR3 in Advanced NSCLC
1M ago
6K
NBTX
Nanobiotix’s Strategic Partnership and Financial Stability Justify Buy Rating
Premium
Ratings
Nanobiotix’s Strategic Partnership and Financial Stability Justify Buy Rating
2M ago
NBTX
Nanobiotix Presents Promising Phase 1 Study Data on NBTXR3 at European Conference
PremiumCompany Announcements
Nanobiotix Presents Promising Phase 1 Study Data on NBTXR3 at European Conference
2M ago
6K
NBTX
Nanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
PremiumRatings
Nanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
2M ago
NBTX
Strategic Licensing Amendment with Janssen Bolsters Nanobiotix’s Financial Outlook and Justifies Buy Rating
PremiumRatings
Strategic Licensing Amendment with Janssen Bolsters Nanobiotix’s Financial Outlook and Justifies Buy Rating
2M ago
NBTX
Nanobiotix Strengthens Financial Position with Amended Licensing Agreement
PremiumCompany Announcements
Nanobiotix Strengthens Financial Position with Amended Licensing Agreement
2M ago
6K
NBTX
Nanobiotix amends global licensing agreement with Janssen Pharmaceutica
PremiumThe FlyNanobiotix amends global licensing agreement with Janssen Pharmaceutica
2M ago
JNJ
NBTX
Nanobiotix Announces Voting Rights and Share Capital Details
Premium
Company Announcements
Nanobiotix Announces Voting Rights and Share Capital Details
2M ago
6K
NBTX
Nanobiotix files $200M mixed securities shelf
Premium
The Fly
Nanobiotix files $200M mixed securities shelf
2M ago
NBTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >